References
Carrazana E, Mikoshiba I (2003) Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manag 25(5 Suppl):S31–S35
Chantaphakul H, Sanon T, Klaewsongkram J (2015) Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med 10:519–524
Cruccua G, Gronsethb G, Alksnec J, Argoffd C, Brainine M, Burchiel K, et al. (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15:1013–1028
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113–1123
Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, Thomsen LL, et al. (2012) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain 13(Suppl 1):S1–S29
Kutluay E, McCague K, D'Souza J, Beydoun A (2003) Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 4:175–180.
Hellewell JS (2002) Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J Affect Disord 72(Suppl 1):S23–S34
Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34
Besi E, Boniface DR, Cregg R, Zakrzewska JM (2015) Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP). J Headache Pain 16:563
Saconato H, Prado GF, Puga ME, Atallah AN (2009) Oxcarbazepine for refractory epilepsy: systematic review of the literature. Sao Paulo Med J 127:150–159
Dirección General de Medicamentos, Insumos y Drogas (2015) Observatorio de productos farmacéuticos. Lima, DIGEMID.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poletti-Jabbour, J., Wiegering-Rospigliosi, A., Pereyra-Elías, R. et al. Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap. Eur J Clin Pharmacol 72, 1031–1032 (2016). https://doi.org/10.1007/s00228-016-2066-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-016-2066-5